Furthermore, emerging evidence have proven that elevated expression of leptin and its receptors might potentially contribute to the progression of many tumors, including endometrioid endometrial cancer [10], breast cancer [13], and liver cancer [14]. This evidence concerns the gene LEP and breast carcinoma.